Comprehensive Perioperative Program Based on Prehabilitation, Nutritional Intervention and Psychological Support for Patients With Locally Advanced Operable Oesophagogastric Cancer
Recruiting
N/A
Interventional Study
Locally Advanced Esophageal Cancer
Gastroesophageal Junction Cancer
Gastric Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 60 (estimated)
- Sponsor
- Masaryk Memorial Cancer Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Perioperative chemotherapy (CHT) or CHT/RT combined with surgery is the standard therapeutic approach for the treatment of locally advanced cancer of the esophagus, gastroesophageal junction (GEJ), and stomach. Comprehensive cancer treatment is associated with high perioperative morbidity and mortality. Serious postoperative complications occur in up to 20-80% of patients undergoing esophagectomy.…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Consent to participate in the study
* Age ≥ 18 years
* Patients with locally advanced esophageal or gastric cancer indicated for comprehensive perioperative treatment
* Resectable disease
* ECOG performance status 0-2
* Ability to participate in a fitness program
* Willingness…
Contacts